Evaluating the role of preoperative plasma insulin-like growth factor 1 (IGF-1) as a predictor of survival and recurrence in patients with resectable hepatocellular carcinoma.

Authors: Joe Eid, Antony Haddad, Sunyoung S. Lee, Zishuo Ian Hu, Manal Hassan, Hesham M. Amin, Timothy E. Newhook, Ching-Wei D. Tzeng, Jean-Nicolas Vauthey, Yun Shin Chun, Emad D. Singer, Hop Sanderson Tran Cao, Ahmed Omar Kaseb

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e16318

Source: Full article


Abstract

e16318